Biomarker discovery in highly invasive lung cancer cell through proteomics approaches. (1st November 2020)

• Record Type: Journal Article
• Authors: Kuo, Chin‐Ho; Lin, Meng‐Wei; Hsu, Yu‐Wei; Chou, Hsiu‐Chuan; Lin, Li‐Hsun; Law, Ching‐Hsuan; Lin, Yi‐Chieh; Hu, Ren‐Yu; Kuo, Wen‐Hung; Ko, Mei‐Lan; Chang, Shing‐Jyh; Lee, Ying‐Ray; Chan, Hong‐Lin
• Is Part Of: Cell biochemistry and function. Volume 39:Number 3(2021)
• Page Start: 367
• Page End: 379
• Publication Date: 2020-11-01
• Subjects: EMT -- lung cancer cell -- metastasis -- NSCLC -- proteomics; Cytochemistry -- Periodicals; Cell metabolism -- Periodicals; Biochemistry -- Periodicals; Cytology -- Periodicals; 572
• DOI: 10.1002/cbf.3599
• Languages: English
• ISSNs: 0263-6484

Abstract

Abstract : Lung cancer is one of the leading causes of cancer‐related death worldwide. The most common type of lung cancer is non‐small cell lung cancer (NSCLC). When NSCLC is detected, patients are typically already in a metastatic stage. Metastasized cancer is a major obstacle of effective treatment and understanding the mechanisms underlying metastasis is critical to treat cancer. Herein, we selected an invasive subpopulation from the human lung cancer cell line A549 using the transwell system and named it as A549‐I5. Invasive and migratory activities of this cell line were analysed using wound healing, invasion, and migration assays. In addition, epithelial‐mesenchymal transition (EMT) markers, such as Snail 1, Twist, Vimentin, N‐cadherin and E‐cadherin, were assessed through immunoblotting. In comparison to A549 cells, the invasive A549‐I5 lung cancer cells had enhanced invasiveness, motility and EMT marker expression. Proteomic analysis identified 83 significantly differentially expressed proteins in A549‐I5 cells. These identified proteins were classified according to their cellular functions and most were involved in cytoskeleton, redox regulation, protein degradation and protein folding. In summary, our results provide potential diagnostic markers and therapeutic candidates for the treatment of NSCLC metastasis. Significance of the study: When NSCLC is detected, most patients are already in a metastatic stage. Herein, we selected an invasive subpopulation from a human lung cancer cell line which had increased EMT markers as well as high wound healing, invasion and migration abilities. Proteomic analysis identified numerous proteins associated with functions in cytoskeleton, redox regulation, protein degradation and protein folding that were differentially expressed in these cells. These results may provide potential diagnostic markers and therapeutic candidates for the treatment of NSCLC metastasis.